Afficher la couverture 'Deprescribing cholinesterase inhibitors at the end of life #354 | LIAO, Pamela' en grand format
/5

0 avis

Deprescribing cholinesterase inhibitors at the end of life #354

Article indépendant

LIAO, Pamela | PERRI, Giulia-Anna

Cholinesterase inhibitors (CHEIs) are the most commonly prescribed agents to delay the progression of cognitive decline from dementia, Parkinson's disease, and other degenerative neurologic diseases. Yet, as dementia progresses, the effectiveness of CHEIs diminish while adverse effects can mount. Other Fast Facts addressed dementia's natural history (# 150) and tension points in medical decision making (# 84). This Fast Facts addresses deprescribing considerations for CHEIs.

http://dx.doi.org/10.1089/jpm.2018.0220

Voir la revue «JOURNAL OF PALLIATIVE MEDICINE, 21»

Autres numéros de la revue «JOURNAL OF PALLIATIVE MEDICINE»

Consulter en ligne

Suggestions

Du même auteur

Deprescribing cholinesterase inhibitors at th...

Article | LIAO, Pamela | JOURNAL OF PALLIATIVE MEDICINE | n°7 | vol.21

Cholinesterase inhibitors (CHEIs) are the most commonly prescribed agents to delay the progression of cognitive decline from dementia, Parkinson's disease, and other degenerative neurologic diseases. Yet, as dementia progresses, t...

Deprescribing cholinesterase inhibitors at th...

Article indépendant | LIAO, Pamela | JOURNAL OF PALLIATIVE MEDICINE | n°7 | vol.21

Cholinesterase inhibitors (CHEIs) are the most commonly prescribed agents to delay the progression of cognitive decline from dementia, Parkinson's disease, and other degenerative neurologic diseases. Yet, as dementia progresses, t...

Bleeding management in hospice care settings ...

Article indépendant | LIAO, Pamela | JOURNAL OF PALLIATIVE MEDICINE | n°12 | vol.20

Bleeding is a distressing, complex, and relatively common symptom in palliative care. It can present at many anatomical sites and vary in acuity and presentation. This Fast Fact provides an approach to managing noncatastrophic ble...

De la même série

Feasibility of a palliative care intervention...

Article indépendant | VERMA, Manisha | JOURNAL OF PALLIATIVE MEDICINE | n°3 | vol.36

Background: Patients with hepatocellular cancer (HCC) are at risk for poor quality of life (QoL) and high symptom burden, coupled with limited treatment options. Palliative care (PC) can play an important role in reducing the suff...

"You suffer from being interested" : a tribut...

Article indépendant | MILLER, Pringl | JOURNAL OF PALLIATIVE MEDICINE | n°12 | vol.31

I met Hank during my palliative medicine fellowship after his nurse Cynthia paged me to request a consult for existential suffering. When reviewing Hank's electronic medical record, it became evident he was dying and averse to spe...

Human-centered design development and accepta...

Article indépendant | FROMME, Erik K. | JOURNAL OF PALLIATIVE MEDICINE | n°5 | vol.28

Introduction: Home hospice medication management ideally addresses symptoms, reduces unnecessary medication use, and optimizes quality of life. Grounding decisions in goals of care is critical. How to ascertain and align patients'...

Top ten tips palliative care clinicians shoul...

Article indépendant | CHUNG, Jenny E. | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

As of 2019, there are 4.2 million Filipino Americans (FAs) and 1.9 million Korean Americans (KAs) in the United States, largely concentrated in New York, California, Texas, Illinois, and Washington. In both populations, similar to...

Interventions for family caregivers of patien...

Article indépendant | ALSHAKHS, Sulaiman | JOURNAL OF PALLIATIVE MEDICINE | n°1 | vol.27

There is a need for understanding the breadth of interventions for caregivers of individuals receiving hospice care at home, given the important role caregivers play in caring and the negative outcomes (e.g., depression) associate...

Chargement des enrichissements...